• Strong data from Sequana Medical's DSR® proof-of-concept studies in heart failure published in European Journal of Heart Failure

    Wednesday April 3rd 2024

  • Sequana Medical announces three month follow-up data from MOJAVE non-randomized cohort confirming dramatic improvement in diuretic response and virtual elimination of loop diuretics following DSR® therapy

    Monday March 25th 2024

  • DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase

    Wednesday February 28th 2024

  • Rejuvenate Biomed’s clinical trial demonstrates the therapeutic potential of RJx-01 in sarcopenia

    Wednesday February 21st 2024

  • Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure

    Tuesday January 23rd 2024

  • KU Leuven researchers discover how to break the negative feedback loop to improve cancer immunotherapy

    Tuesday January 16th 2024

  • Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients

    Wednesday December 20th 2023

  • argenx reports topline results from ADDRESS study of efgartigimod SC in pemphigus

    Wednesday December 20th 2023

  • Your news here?

  • Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301

    Wednesday December 20th 2023

  • Biotalys announces results of independent field trials in the U.S.

    Tuesday December 19th 2023

  • Mithra receives positive DSMB Opinion on DONESTA® European Phase 3 Trial

    Monday December 18th 2023

Strategic Partners